Results 101 to 110 of about 184,390 (149)

Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinoma. [PDF]

open access: yesSci Rep
Li S   +21 more
europepmc   +1 more source

Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody. [PDF]

open access: yesCancer Immunol Immunother
Zaninelli S   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy